Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer
Clinical trial NCT05239533 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05239533
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2027-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.